tak 044 has been researched along with Brain Ischemia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Briyal, S; Gulati, A; Gupta, YK; Jagannathan, NR; Sharma, U | 1 |
Briyal, S; Gulati, A; Gupta, YK | 1 |
Bell, BA; Murray, GD; Pickard, JD; Shaw, MD; Teasdale, GM; Vermeulen, M | 1 |
1 trial(s) available for tak 044 and Brain Ischemia
Article | Year |
---|---|
Efficacy and safety of the endothelin, receptor antagonist TAK-044 in treating subarachnoid hemorrhage: a report by the Steering Committee on behalf of the UK/Netherlands/Eire TAK-044 Subarachnoid Haemorrhage Study Group.
Topics: Adult; Aged; Brain Ischemia; Double-Blind Method; Endothelin Receptor Antagonists; Female; Follow-Up Studies; Glasgow Outcome Scale; Humans; Male; Middle Aged; Peptides, Cyclic; Receptor, Endothelin A; Receptor, Endothelin B; Subarachnoid Hemorrhage; Survival Rate; Vasospasm, Intracranial | 2000 |
2 other study(ies) available for tak 044 and Brain Ischemia
Article | Year |
---|---|
Effect of endothelin antagonist (TAK-044) on cerebral ischemic volume, oxidative stress markers and neurobehavioral parameters in the middle cerebral artery occlusion model of stroke in rats.
Topics: Animals; Behavior, Animal; Biomarkers; Brain Ischemia; Diffusion Magnetic Resonance Imaging; Disease Models, Animal; Endothelins; Glutathione; Infarction, Middle Cerebral Artery; Male; Malondialdehyde; Motor Activity; Oxidative Stress; Peptides, Cyclic; Rats; Rats, Wistar; Superoxide Dismutase | 2005 |
Effect of combination of endothelin receptor antagonist (TAK-044) and aspirin in middle cerebral artery occlusion model of acute ischemic stroke in rats.
Topics: Animals; Antioxidants; Aspirin; Brain Ischemia; Disease Models, Animal; Drug Therapy, Combination; Endothelin Receptor Antagonists; Glutathione; Infarction, Middle Cerebral Artery; Male; Malondialdehyde; Motor Activity; Neuroprotective Agents; Oxidative Stress; Peptides, Cyclic; Rats; Rats, Wistar; Receptors, Endothelin; Stroke; Superoxide Dismutase | 2007 |